Brimonidine: all 110 studies that test it
Page 1 of 2. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Upneeq vs. Lumify PtosisNot yet recruitingNCT07390578Phase 4
- Safety and Efficacy Study of TAR-0520 Gel in Prevention of Taxane-induced Peripheral NeuropathyNot yet recruitingNCT07082764Phase 2
- Brimonidine Eye Drops in the Prevention of Myopia ProgressionNot yet recruitingNCT06996236Phase 2
- TAR-0520 Gel in EGFR Inhibitor-induced FolliculitisRecruitingNCT06818058Phase 2
- The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma PatientsNot yet recruitingNCT04007276Phase 4
- Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic SolutionCompletedNCT05815758Phase 3Results posted
- Phase 3 Safety Study of LNZ100 and LNZ101 for the Treatment of Presbyopia SubjectsCompletedNCT05753189Phase 3Results posted
- Phase 3 Efficacy Study of LNZ100 & LNZ101 for the Treatment of PresbyopiaCompletedNCT05728944Phase 3Results posted
- Phase 3 Evaluation of the Safety and Efficacy of LNZ100 & LNZ101 for the Treatment of PresbyopiaCompletedNCT05656027Phase 3Results posted
- Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic ConjunctivitisCompletedNCT05591755Phase 3Results posted
- Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisCompletedNCT05579730Phase 3Results posted
- Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of PresbyopiaCompletedNCT05431543Phase 2Results posted
- "Efficacy and Safety of Brimonidine Tartrate Preservative-Free Formulation in Adults With Ocular Redness"CompletedNCT05360784Phase 3Results posted
- Evaluation of the Safety and Effectiveness of Aceclidine/Brimonidine (LNZ101) and Aceclidine (LNZ100) in the Treatment of PresbyopiaCompletedNCT05294328Phase 2Results posted
- Safety and Efficacy Study BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic or Pseudophakic PresbyopiaCompletedNCT05270863Phase 3Results posted
- Safety and Efficacy Study of BRIMOCHOL™, BRIMOCHOL™ F, and Carbachol in Subjects With Emmetropic Phakic and Pseudophakic PresbyopiaCompletedNCT04774237Phase 2Results posted
- The Effect of BrimonidineCompletedNCT03959176Phase 4Results posted
- Study of Brimonidine Tartrate Nanoemulsion Eye Drop Solution in the Treatment of Dry Eye Disease (DED)CompletedNCT03785340Phase 3Results posted
- The Effect of Lumify™ Eyedrops on Eyelid PositionCompletedNCT03782701Phase 4Results posted
- Pupil Dilation for Treatment of IFISCompletedNCT03760185Phase 2Results posted
- Study of Brimonidine Tartrate Nanoemulsion Eye Drops in Patients With Ocular Graft-vs-Host DiseaseTerminatedNCT03591874Phase 3Results posted
- Evaluation of Safety and Efficacy of PDP-716CompletedNCT03450629Phase 3Results posted
- Dry Eye Disease Study With BrimonidineCompletedNCT03418727Phase 2Results posted
- Peripapillary Blood Flow After Use of Anti-glaucoma Medications: An OCT Angiography StudyCompletedNCT03323164Phase 4Results posted
- Brinzolamide/Brimonidine Combination vs Brimonidine 0.2% in the Prevention of IOP Rise After Nd-YAG Laser CapsulotomyCompletedNCT03192826Phase 4Results posted
- Internet Surveys and Their Impact on Adherence for RosaceaCompletedNCT03048058Phase 4Results posted
- Brimonidine Eye Drops for Treatment of Ocular Graft-vs-Host Disease (oGVHD)TerminatedNCT02975557Phase 1/2Results posted
- MirvasO Soolantra Association In the Treatment of Moderate to Severe rosaCea.CompletedNCT02616250Phase 4Results posted
- Randomized, Double-blind, Multiple-site, Placebo-controlled, Parallel-design Study in Patients With Moderate to Severe Facial Erythema Associated With RosaceaCompletedNCT02289352Phase 3Results posted
- Mirvaso in Use StudyCompletedNCT02249065Phase 4Results posted
- A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular DegenerationTerminatedNCT02087085Phase 2Results posted
- A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular HypertensionCompletedNCT02003534Phase 4Results posted
- Safety of Brimonidine Tartrate Ophthalmic Solution in a Population of Pediatric, Adult, and Geriatric ParticipantsCompletedNCT01959243Phase 3Results posted
- Efficacy and Safety of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric Participants With Ocular RednessCompletedNCT01959230Phase 3Results posted
- A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular HypertensionCompletedNCT01525173Phase 4Results posted
- Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With RosaceaCompletedNCT01355471Phase 3Results posted
- Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With RosaceaCompletedNCT01355458Phase 3Results posted
- Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With RosaceaCompletedNCT01318733Phase 3Results posted
- Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01241240Phase 3Results posted
- Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular HypertensionCompletedNCT01229462Not applicableResults posted
- Pharmacokinetics of the Brimonidine Tartrate Posterior Segment Delivery System in Patients Undergoing Pars Plana VitrectomyCompletedNCT01229410Phase 1Results posted
- Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular HypertensionCompletedNCT01217606Phase 3Results posted
- Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Facial Erythema Associated With RosaceaCompletedNCT01174030Phase 2Results posted
- Study of Brimonidine and Timolol Ophthalmic Solution With Latanoprost Compared With Latanoprost in Glaucoma PatientsTerminatedNCT01151904Phase 4Results posted
- Aqueous Humor Dynamics and BrimonidineCompletedNCT01144494Early Phase 1Results posted
- Effect of Alphagan on Retinal Blood Flow Autoregulation and Motion Detection in Patients With Normal Pressure GlaucomaCompletedNCT01105065Not applicableResults posted
- Dose-Finding Study of CD07805/47 Topical Gel in Subjects With Erythematotelangiectatic RosaceaCompletedNCT00989014Phase 2Results posted
- Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual FunctionCompletedNCT00972374Phase 2Results posted
- Effect of Cosopt Versus Combigan on Retinal Vascular Autoregulation in Primary Open Angle Glaucoma (POAG)CompletedNCT00824824Not applicableResults posted
- Circadian Ocular Perfusion Pressure and Ocular Blood FlowCompletedNCT00800540Phase 4Results posted
- Systemic Bioavailability Study Of Col-118 Administered Topically as a 0.18 % Facial Gel And Brimonidine Ophthalmic Solution 0.2%CompletedNCT00697541Phase 2Results posted
- Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic NeuropathyCompletedNCT00693485Phase 2Results posted
- An Exploratory Study to Evaluate the Safety of Brimonidine Intravitreal Implant in Patients With Retinitis PigmentosaCompletedNCT00661479Phase 1/2Results posted
- Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD)CompletedNCT00658619Phase 2Results posted
- 24-hour IOP-lowering Effect of Brimonidine 0.1%CompletedNCT00457795Phase 4Results posted
- Brimonidine 0.33% for Rosacea-Related Facial ErythemaCompletedNCT07431476Phase 4
- Optic Nerve Perfusion Following Treatment with Latanoprost Versus Brimionidin TartrateCompletedNCT06730516Early Phase 1
- Evaluation of the Efficacy and Safety of LNZ101 and LNZ100 for the PresbyopiaCompletedNCT06045299Phase 3
- Plasma Pharmacokinetics and Safety of LNZ101 and LNZ100 Ophthalmic Solutions in Healthy Adult Subjects With PresbyopiaCompletedNCT05936489Phase 1
- Brimonidine for Intraoperative HemostasisWithdrawnNCT05480098Phase 4
- The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTACompletedNCT05474716Phase 4
- Safety and Efficacy Study of BRIMOCHOL™ PF and Carbachol PF in Subjects With Emmetropic Phakic and Pseudophakic PresbyopiaCompletedNCT05135286Phase 3
- Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic PatientsStatus unknownNCT05001243Phase 1
- Brimonidine Tartrate for Pterygium SurgeryStatus unknownNCT04683159Not applicable
- Comparison of Efficacy and Ocular Surface Disease Assessment Between BRIDIN-T Eye Drops 0.15% and ALPHAGAN-P Eye Drops 0.15% in Glaucoma or Ocular Hypertensive Patients : Phase 4, Parallel Group Design, Investigator-blind, Active-control, Randomized, Multi-center TrialStatus unknownNCT04647461Phase 4
- Brimonidine for Subconjunctival Hemorrhage From Femtosecond Laser Assisted Cataract SurgeryCompletedNCT04633954Not applicable
- Choroidal Thickness and Its Correlations With Ocular Parameters in Primary Open-angle GlaucomaCompletedNCT03966560Phase 4
- Pilocarpine and Brimonidine in Patients With Monofocal LensesStatus unknownNCT03825081Early Phase 1
- Pre-Administration of Brimonidine in Intravitreal Anti-VEGF TherapyCompletedNCT03513172Not applicable
- Mirvaso® Gel and Dysport® for Erythema and Flushing of RosaceaTerminatedNCT03508869Not applicable
- Treatment of Asian Flushing Syndrome With Topical Alpha AgonistsCompletedNCT03497442Early Phase 1
- The Effect of Topical Brimonidine Tartrate on Hand-foot Syndrome (HFS) in Cancer PatientsTerminatedNCT03173365Phase 2
- The Effect of Brimonidine on Intraocular Pressure When Dilating Routine PatientsCompletedNCT03139708Phase 1
- A Multicenter, Open-label Clinical Trial to Evaluate the Efficacy and Safety of Once Daily Mirvaso® Gel in Patients With Chronic Persistent Vascular Facial Erythema.CompletedNCT02856919Phase 4
- Preoperative Brimonidine on IOP of Patients Undergoing RALPCompletedNCT02818816Phase 4
- Onreltea (Brimonidine) Gel In Pediatric Patients With Capillary MalformationsTerminatedNCT02764411Phase 3
- Topical Brimonidine to Reduce Inflammation After IPL-treatment in Patients With Facial TelangiectasiasCompletedNCT02761174Phase 4
- Brimonidine Tartrate for the Treatment of Injection Related ErythemaWithdrawnNCT02568111Phase 4
- Effect of Antiglaucoma Agents on Short Term Intraocular Pressure Fluctuations After Intravitreal Bevacizumab InjectionCompletedNCT02140450Not applicable
- Pharmacokinetics and Safety of Topical Administration of Brimonidine Tartrate Ophthalmic Solution 0.025%.CompletedNCT02039765Phase 1
- Phase 3 Efficacy and Safety Study of CD07805/47 Topical Gel in Subjects With Persistent Facial ErythemaWithdrawnNCT01882712Phase 3
- Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic RetinopathyCompletedNCT01726075Phase 2/3
- Study Evaluating the Safety and Intraocular Pressure (IOP) Lowering Response of Brimonidine Tartrate Ophthalmic Solution in Subjects With Open Angle Glaucoma or Ocular HypertensionCompletedNCT01687426Phase 1
- Study Evaluating the Safety and Efficacy of Brimonidine Tartrate Ophthalmic Solution in Adult and Geriatric SubjectsCompletedNCT01675609Phase 2
- Intraocular Pressure (IOP) Lowering Efficacy of Transdermal Brimonidine TherapyStatus unknownNCT01345448Phase 2
- A Single-Center, Randomized, Double-Masked, Placebo and Active Controlled, Dose-Ranging Evaluation of the Duration of Action of Brimonidine Tartrate Ophthalmic Solution in the Control of Ocular Redness Induced by Conjunctival Allergen Challenge (CAC)CompletedNCT01275105Phase 2
- Effect of Alphagan and Xalatan Eye Drops on Corneal TemperatureCompletedNCT01201551Not applicable
- 24-hr Intraocular Pressure Control With Dorzolamide/Timolol vs the Brimonidine/Timolol Fixed CombinationCompletedNCT00972257Phase 4
- Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal BevacizumabCompletedNCT00864838Phase 2
- Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00822081Phase 4
- Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular HypertensionCompletedNCT00822055Phase 4
- Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After BevacizumabCompletedNCT00804921Phase 2
- Effect of Topical Brimonidine on Post Cataract Surgery Corneal EdemaStatus unknownNCT00800423Phase 3
- Relation Between Intraocular Pressure Lowering Effects of Topical Brimonidine and Alpha 2 Receptor PolymorphismWithdrawnNCT00712777Not applicable
- Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)CompletedNCT00698945Phase 4
- Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin AnalogsCompletedNCT00675207Phase 4
- Safety and Efficacy Study of Brimonidine in Patients With Glaucoma or Ocular HypertensionCompletedNCT00652483Phase 3
- Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension PatientsCompletedNCT00651612Phase 3
- Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser TrabeculoplastyStatus unknownNCT00567411Not applicable
- Brimonidine vs ALTP in Progressing Human GlaucomaCompletedNCT00466479Phase 4